Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor.
But what's the best way to find the right combination of stocks? Because funding things like your retirement, your kids' college tuition, or your short- and long-term savings goals will definitely require significant returns.
Enter the Zacks Rank.
What is the Zacks Rank?
A unique, proprietary stock-rating model, the Zacks Rank uses earnings estimate revisions, or changes to a company's earnings expectations, to help investors create a winning portfolio.
There are four main factors behind the Zacks Rank: Agreement, Magnitude, Upside, and Surprise.
Agreement is the extent to which all brokerage analysts are revising their earnings estimates in the same direction. The greater the percentage of analysts revising their estimates higher, the better chance the stock will outperform.
Magnitude is the size of the recent change in the consensus estimate for the current and next fiscal years.
Upside is the difference between the most accurate estimate, which is calculated by Zacks, and the consensus estimate.
Surprise is made up of a company's last few quarters' earnings per share surprises; companies with a positive earnings surprise are more likely to beat expectations in the future.
These four factors are assigned a raw score that's recalculated every night, which is then compiled into the ranking system. Stocks are classified into five groups using this data, ranging from "Strong Buy" to "Strong Sell."
The Power of Institutional Investors
The Zacks Rank also allows individual investors, or retail investors, to benefit from the power of institutional investors.
Institutional investors are responsible for managing the trillions of dollars invested in mutual funds, hedge funds, and investment banks. Research has shown that these investors can and do move the market due to the large amount of money they deal with, and thus, the market tends to move in the same direction as them.
These investors are known for designing valuation models that focus on earnings and earnings expectations in order to figure out the fair value of a company and its shares. If earnings estimates are raised, it puts a higher value on a company.
With these changes, institutional investors will act, usually buying stocks with rising estimates and selling those with falling estimates. An increase in earnings expectations can potentially lead to higher stock prices and bigger gains for the investor.
Since it can often take weeks, if not months, for an institutional investor to build a position (given their size), retail investors who get in at the first sign of upward earnings estimate revisions have a distinct advantage over these larger investors, and can benefit from the expected institutional buying that will follow.
Not only can the Zacks Rank help you take advantage of trends in earnings estimate revisions, but it can also provide a way to get into stocks that are highly sought after by professionals.
How to Invest with the Zacks Rank
The Zacks Rank is known for transforming investment portfolios. In fact, a portfolio of Zacks Rank #1 (Strong Buy) stocks has beaten the market in 26 of the last 32 years, with an average annual return of +25.41%.
Moreover, stocks with a new #1 (Strong Buy) ranking have some of the biggest profit potential, while those that fell to a #4 (Sell) or #5 (Strong Sell) have some of the worst.
Let's take a look at
HCA Healthcare (HCA)
, which was added to the Zacks Rank #1 list on September 12, 2024.
HCA Healthcare is the largest non-governmental operator of acute care hospitals in the United States. Headquartered in Nashville, TN, it operates hospitals and related health care entities. At the end of 2023, the company operated 186 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.
10 analysts revised their earnings estimate upwards in the last 60 days for fiscal 2024. The Zacks Consensus Estimate has increased $1.49 to $22.46 per share. HCA boasts an average earnings surprise of 8.2%.
Earnings are forecasted to see growth of 18.2% for the current fiscal year, and sales are expected to increase 8.9%.
Even more impressive, HCA has gained in value over the past four weeks, up 5.9% compared to the S&P 500's gain of 1.6%.
Bottom Line
With a #1 (Strong Buy) ranking, positive trend in earnings estimate revisions, and strong market momentum, HCA Healthcare should be on investors' shortlist.
If you want even more information on the Zacks Ranks, or one of our many other investing strategies, check out the Zacks Education home page.
Discover Today's Top Stocks
Our private Zacks #1 Rank List, based on our quantitative Zacks Rank stock-rating system, has more than doubled the S&P 500 since 1988. Applying the Zacks Rank in your own trading can boost your investing returns on your very next trade. See Today's Zacks #1 Rank List >>
Zacks Investment Research
For Immediate Release
Chicago, IL – September 18, 2024 – Stocks in this week’s article are HCA Healthcare HCA, Hubbell HUBB, Ferrari RACE and Vertex VERX.
4 GARP Stocks to Scoop Up for Maximum Returns
Growth at a reasonable price, or GARP, is an excellent strategy to earn quick investment profits. The GARP approach helps identify stocks priced below the market or any suitable target determined by a fundamental analysis.
The strategy helps investors gain exposure to stocks with impressive prospects and trading at a discount. GARP stocks have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and other metrics.
A portfolio based on the GARP strategy comprises stocks that offer the best value and growth investment. HCA Healthcare, Hubbell, Ferrari and Vertex are some GARP stocks that hold promise.
GARP Metrics — Mix of Growth & Value Metrics
The GARP strategy offers ideal investment options utilizing the best value and growth investing features. Investors adopting the GARP approach prefer stocks priced below the market or any reasonable target determined by fundamental analysis. The stocks have solid prospects based on cash flow, revenues, EPS, etc.
Growth Metrics
A strong earnings growth history and impressive earnings prospects are the primary concepts that GARP investors borrow from the growth investing strategy. However, instead of super-normal rates, pursuing stocks with a more stable and reasonable growth rate is a tactic of GARP investors. The GARP strategy considers growth rates between 10% and 20% ideal.
Another metric considered by growth and GARP investors is the return on equity (ROE). GARP investors look for strong and higher ROE than the industry average to identify superior stocks. Moreover, stocks with a positive cash flow find precedence under the GARP plan.
Value Metrics
GARP investing prioritizes one of the popular value metrics — the price-to-earnings (P/E) ratio. The investing style picks stocks with higher P/E ratios than value investors but it avoids companies with extremely high P/E ratios. The price-to-book value (P/B) ratio is also taken into consideration.
Using the GARP principle, we have run a screen to identify stocks that should offer solid returns in the near term.
Here are four of the five stocks that made it through the screen:
HCA Healthcare is the largest non-governmental operator of acute care hospitals in the United States. These hospitals provide outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. HCA currently sports a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks here.
HCA Healthcare has gained 49.9% year to date. It delivered a trailing four-quarter earnings surprise of 8.24%, on average. The Zacks Consensus Estimate for HCA’a 2024 earnings has moved 7.1% north to $22.46 per share over the past 60 days.
Hubbell designs and manufactures electrical and electronic products, such as plugs, receptacles, connectors, data signal processing components, lighting fixtures, and high-voltage test and measurement equipment. The company currently carries a Zacks Rank #2.
Hubbel has gained 25.5% in the year-to-date period. It has a trailing four-quarter earnings surprise of 1.21% on average. The Zacks Consensus Estimate for HUBB’s 2024 earnings has moved 0.7% north to $16.45 per share over the past 60 days.
Ferrari is a leading designer, manufacturer and seller of sports cars. Its products include sports car models like 458 Italia, 488 GTB, 488 Spider, F12 Berlinetta, 458 Speciale and grand tourer cars. RACE currently carries a Zacks Rank #2.
Ferrari has gained 37% year to date. It delivered a trailing four-quarter earnings surprise of 12.3%, on average. The Zacks Consensus Estimate for RACE’s fiscal 2024 earnings has moved 6.2% north to $8.71 per share over the past 60 days.
Vertex provides tax technology solutions like tax determination, compliance and reporting, tax data management, document management, pre-built integration, and industry-specific solutions in retail, leasing, communication and manufacturing industries principally across the United States and the international market. The company carries a Zacks Rank #2 at present.
Vertex has gained 71.8% in the year-to-date period. It has a trailing four-quarter earnings surprise of 18.49%, on average. The Zacks Consensus Estimate for HUBB’s 2024 earnings has moved 9.4% north to 58 cents per share over the past 60 days.
Get the remaining stock on the list and start testing this and other ideas. It can all be done with the Research Wizard stock picking and back-testing software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in and see what gems come out.
Click here to sign up for a free trial of the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2337385/4-garp-stocks-to-scoop-up-for-maximum-returns
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks Investment Research
The S&P 500 Index Tuesday closed up by +0.03%, the Dow Jones Industrials Index closed down by -0.04%, and the Nasdaq 100 Index closed up by +0.05%.
Stocks on Tuesday relinquished early gains and closed little changed. Long liquidation pressures emerged in stocks Tuesday afternoon after bond yields rose ahead of the results of the 2-day FOMC meeting are released on Wednesday.
Stocks on Tuesday rallied early in the session, with the S&P 500 and Dow Jones Industrials posting new record highs and the Nasdaq 100 rising to a 2-1/2 week high. Tuesday's positive corporate and economic news boosted optimism in the US economic outlook and supported stocks.
Intel rose more than +2% after the chipmaker won new business from Amazon.com. Also, Microsoft closed up nearly +1% after it raised its quarterly dividend by 10% and announced a new $60 billion stock repurchase program. Stocks also found support from Tuesday’s stronger-than-expected US economic reports on retail sales and manufacturing production that bolstered the outlook for a soft landing.
Aug retail sales unexpectedly rose +0.1% m/m, stronger than expectations of a -0.2% m/m decline. However, Aug retail sales ex-autos rose only +0.1% m/m, slightly weaker than expectations of +0.2% m/m.
US Aug manufacturing production rose +0.9% m/m, stronger than expectations of +0.2% m/m and the largest increase in 6 months.
The US Sep NAHB housing market index rose +2 to 41, right on expectations.
The markets will look to the 2-day FOMC meeting that concludes Wednesday afternoon to see whether policymakers will decide that a -25 bp cut in the fed funds target range would be adequate for a US economy that has shown signs of losing momentum or whether they will decide on a larger -50 bp rate cut instead. Post-meeting comments from Fed Chair Powell on Wednesday will also be scrutinized regarding the Fed’s future policy intentions.
The markets are discounting the chances at 100% for a -25 bp rate cut for the Tue/Wed FOMC meeting and at 69% for a -50 bp rate cut at that meeting.
Overseas stock markets Tuesday settled mixed. The Euro Stoxx 50 climbed to a 1-1/2 week high and closed up +0.69%. China's Shanghai Composite was closed for the Mid-Autumn Festival holiday. Japan's Nikkei Stock 225 closed down -1.03%.
Interest Rates
December 10-year T-notes (ZNZ24) Tuesday closed down -6 ticks. The 10-year T-note yield rose +2.0 bp to 3.638%. Dec T-notes Tuesday gave up early gains and turned lower, and the 10-year T-note yield rebounded from a 15-month low of 3.595% and moved higher. The stronger-than-expected US retail sales and manufacturing production reports weighed on T-note prices. Also, an increase in inflation expectations weighed on T-notes after the 10-year breakeven inflation rate rose to a 2-week high Tuesday of 2.118%. In addition, weak demand for the Treasury’s $13 billion 20-year T-bond auction undercut T-notes as the auction had a bid-to-cover ratio of 2.51, well below the 10-auction average of 2.61.
T-notes on Tuesday initially moved higher on heightened speculation the Fed will cut interest rates by -50 bp at this week’s 2-day FOMC meeting. Swap markets showed the chances of a -50 bp rate cut rose to 69% Tuesday from 52% last Friday.
European government bond yields on Tuesday moved higher. The 10-year German bund yield rose +2.1 bp to 2.143%. The 10-year UK gilt yield rebounded from a 7-1/2 month low of 3.729% and finished up +0.9 bp at 3.768%.
The German Sep ZEW survey expectations of economic growth index fell -15.6 to an 11-month low of 3.6, weaker than expectations of 17.0.
ECB Governing Council member Simkus said the likelihood of an October interest rate cut by the ECB is "very small."
Swaps are discounting the chances of a -25 bp rate cut by the ECB at 32% for the October 17 meeting.
US Stock Movers
Intel closed up more than +2% to lead gainers in the Dow Jones Industrials and Nasdaq 100 after the chipmaker landed Amazon.com’s AWS as a customer for its chip manufacturing business.
HP Enterprise closed up more than +5% after Bank of America Global Research upgraded the stock to buy from neutral with a price target of $24.
Moderna closed up more than +3% to lead gainers in the Nasdaq 100 after Health Canada approved the company’s updated Covid-19 vaccine for use.
Airbnb closed up more than +3% after Uber won its fight against a state government claim in Australia that ruled its payments to drivers were not wages, which bolstered speculation other businesses with similar payment arrangements to Uber’s may benefit from its win in a long-standing payroll tax dispute.
Health insurance stocks were under pressure Tuesday, with Cigna Group and Molina Healthcare closing down more than -2%. Also, Centene , Cardinal Health , Elevance Health , and HCA Healthcare closed down more than -1%.
Accenture Plc closed down more than -4% to lead losers in the S&P 500 after Bloomberg News reported the company plans to push back the bulk of its staff promotions by six months as a weak outlook is curbing IT spending.
Atlassian closed down more than -6% to lead losers in the Nasdaq 100 on signs of insider selling after an SEC filing showed CEO Cannon-Brookes sold $1.31 million shares last Friday.
AppLovin closed up more than +6% after UBS upgraded the stock to buy from neutral with a price target of $145.
GE Vernova closed up more than +2% after Bank of America Global Research upgraded the stock to buy from neutral with a price target of $300.
Dell Technologies closed up more than +1% after Mizuho Securities initiated coverage on the stock with a recommendation of outperform and a price target of $135.
Microsoft closed up nearly +1% after it raised its quarterly dividend by 10% and announced a new $60 billion stock repurchase program.
Acushnet Holdings closed down more than -3% after Jeffries downgraded the stock to hold from buy.
S&P Global Inc closed down nearly -1% after it was removed from Bank of America Global Research’s US number 1 list.
Earnings Reports (9/18/2024)
Ennis Inc (EBF), General Mills Inc (GIS), Steelcase Inc (SCS).
On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policyhere.
HCA Healthcare, Inc. HCA shares have gained 18.4% in the past three months, outperforming the hospital industry and the S&P 500 Index. Over this time frame, the industry and the S&P 500 Index have gained 16% and 2.2%, respectively.
Currently priced at $403.43, the stock is less than 1% below its 52-week high. This proximity underscores investor confidence and market optimism about this hospital company’s prospects. Moreover, the stock is trading above its 50-day and 200-day moving averages, signaling strong upward momentum.
HCA 3-Month Price Performance
HCA’s Growth Prospects
Growing volumes is an important determinant for a healthcare facility operator like HCA Healthcare. The company is seeing elevated demand for its services driven by aging baby boomers, a higher number of people under insurance coverage through their employers or exchanges, COVID migration patterns, and increasing market share. The company saw a 6.4% year-over-year increase in admissions during the first half of 2024. Expected strong demand in the coming days poises the company’s top line well for growth.
The company is effectively meeting growing volumes by expanding capacity and enhancing efficiency, excelling on both fronts. Growing inpatient beds and outpatient facilities are expected to help the company meet the increasing volumes. Reduced length of stay is expected to positively impact the company’s operational efficiency. Contract labor is being managed well, as it came in at 4.8% of the total salaries, wages, and benefits, lower than 6.8% in the year-ago quarter.
Another aspect of margin improvement HCA is focusing on is artificial intelligence (AI). It can be used for staffing, scheduling, revenue cycle management etc. Although the company is still in the early stages of implementing AI, it expects the technology component of its capital expenditures to continue growing. The company expects to incur $5.1-$5.2 billion in capital expenditures in 2024 to expand existing operations. A strong footprint in its rapidly growing markets, such as Florida and Texas, bode well.
HCA’s strong prospects led it to revise its top-line guidance upward between $69.8 billion and $71.8 billion in 2024 from the previous guidance of $67.8 billion-$70.3 billion. It projects adjusted EBITDA in the range of $13.8-$14.3 billion for 2024, up from $12.9-$13.6 billion.
HCA Healthcare’s strong profitability enables it to consistently enhance shareholder value. In the last reported quarter, it returned $1.4 billion to shareholders through share buybacks and $170 million as dividends. The company had $4.2 billion remaining under its repurchase program as of June 30, 2024. It expects to repurchase shares worth $6 billion in 2024. With a dividend yield of 0.65%, HCA is ahead of the industry average of 0.51%.
HCA’s Efficient Capital Utilization
The company’s return on invested capital (ROIC) has been increasing for quite some time. This reflects HCA’s efficiency in utilizing funds to generate income. ROIC in the trailing 12 months was 14.9%, higher than the industry’s average of 12.6%.
Optimistic Analyst Sentiment for HCA
Reflecting the positive sentiment around HCA Healthcare, the Zacks Consensus Estimate for earnings per share has seen upward revisions. The consensus estimate for 2024 adjusted EPS for HCA is currently pegged at $22.46, indicating 18.2% year-over-year growth. The consensus mark for 2025 EPS suggests a further 10.9% jump year over year.
The company beat earnings estimates in three of the past four quarters, missed once, with an average surprise of 8.2%. The consensus estimate for 2024 and 2025 revenues suggests 8.9% and 5.3% year-over-year growth, respectively.
HCA’s Valuation
From a valuation perspective, HCA appears marginally expensive. The company is trading at a forward 12-month price-to-earnings multiple of 16.68X, a bit higher than the industry average of 16.39X.
In comparison, its peers like Tenet Healthcare Corporation THC and Universal Health Services, Inc. UHS are currently trading at forward 12-month price-to-earnings of 15.1X and 13.82X, respectively.
Wrapping Up
HCA Healthcare stock is expected to benefit from strong demand growth, driven by aging demographics, increased insurance coverage, and market expansion. Despite a marginally higher valuation compared to the industry, HCA's upward guidance and commitment to shareholder returns make it an attractive investment to add to your portfolio.The upward revisions in estimates suggest a promising outlook ahead, making this opportunity too good to pass up.
As such, HCA Healthcare currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks Investment Research
Growth at a reasonable price, or GARP, is an excellent strategy to earn quick investment profits. The GARP approach helps identify stocks priced below the market or any suitable target determined by a fundamental analysis.
The strategy helps investors gain exposure to stocks with impressive prospects and trading at a discount. GARP stocks have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and other metrics.
A portfolio based on the GARP strategy comprises stocks that offer the best value and growth investment. HCA Healthcare HCA, Hubbell HUBB, Ferrari RACE and Vertex VERX are some GARP stocks that hold promise.
GARP Metrics — Mix of Growth & Value Metrics
The GARP strategy offers ideal investment options utilizing the best value and growth investing features. Investors adopting the GARP approach prefer stocks priced below the market or any reasonable target determined by fundamental analysis. The stocks have solid prospects based on cash flow, revenues, EPS, etc.
Growth Metrics
A strong earnings growth history and impressive earnings prospects are the primary concepts that GARP investors borrow from the growth investing strategy. However, instead of super-normal rates, pursuing stocks with a more stable and reasonable growth rate is a tactic of GARP investors. The GARP strategy considers growth rates between 10% and 20% ideal.
Another metric considered by growth and GARP investors is the return on equity (ROE). GARP investors look for strong and higher ROE than the industry average to identify superior stocks. Moreover, stocks with a positive cash flow find precedence under the GARP plan.
Value Metrics
GARP investing prioritizes one of the popular value metrics — the price-to-earnings (P/E) ratio. The investing style picks stocks with higher P/E ratios than value investors but it avoids companies with extremely high P/E ratios. The price-to-book value (P/B) ratio is also taken into consideration.
Using the GARP principle, we have run a screen to identify stocks that should offer solid returns in the near term.
Screening Parameters
Along with the criteria discussed in the above section, we have considered a Zacks Rank #1 (Strong Buy) or 2 (Buy).
Last five-year EPS & projected 3-5-year EPS growth rates between 10% and 20% (Strong EPS growth history and prospects ensure improving business.)
ROE (in the past 12 months) greater than the industry average (Higher ROE than the industry average indicates superior stocks.)
P/E and P/B ratios are less than the M-industry average (P/E and P/B ratios less than the industry indicate that the stocks are undervalued.)
Here are four of the five stocks that made it through the screen:
HCA Healthcare is the largest non-governmental operator of acute care hospitals in the United States. These hospitals provide outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. HCA currently sports a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks here.
HCA Healthcare has gained 49.9% year to date. It delivered a trailing four-quarter earnings surprise of 8.24%, on average. The Zacks Consensus Estimate for HCA’a 2024 earnings has moved 7.1% north to $22.46 per share over the past 60 days.
Hubbell designs and manufactures electrical and electronic products, such as plugs, receptacles, connectors, data signal processing components, lighting fixtures, and high-voltage test and measurement equipment. The company currently carries a Zacks Rank #2.
Hubbel has gained 25.5% in the year-to-date period. It has a trailing four-quarter earnings surprise of 1.21% on average. The Zacks Consensus Estimate for HUBB’s 2024 earnings has moved 0.7% north to $16.45 per share over the past 60 days.
Ferrari is a leading designer, manufacturer and seller of sports cars. Its products include sports car models like 458 Italia, 488 GTB, 488 Spider, F12 Berlinetta, 458 Speciale and grand tourer cars. RACE currently carries a Zacks Rank #2.
Ferrari has gained 37% year to date. It delivered a trailing four-quarter earnings surprise of 12.3%, on average. The Zacks Consensus Estimate for RACE’s fiscal 2024 earnings has moved 6.2% north to $8.71 per share over the past 60 days.
Vertex provides tax technology solutions like tax determination, compliance and reporting, tax data management, document management, pre-built integration, and industry-specific solutions in retail, leasing, communication and manufacturing industries principally across the United States and the international market. The company carries a Zacks Rank #2 at present.
Vertex has gained 71.8% in the year-to-date period. It has a trailing four-quarter earnings surprise of 18.49%, on average. The Zacks Consensus Estimate for HUBB’s 2024 earnings has moved 9.4% north to 58 cents per share over the past 60 days.
Get the remaining stock on the list and start testing this and other ideas. It can all be done with the Research Wizard stock picking and back-testing software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in and see what gems come out.
Click here to sign up for a free trial of the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.Disclosure: Performance information for Zacks' portfolios and strategies are available at: https://www.zacks.com/performance.
Zacks Investment Research
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.